RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
Clinical trial NCT07563543 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07563543
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-08
- Primary completion
- 2028-05-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.